Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties

Meryem Saban Güler; Hilal Yıldıran

doi:10.33808/clinexphealthsci.1356783

Review

Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties

Year 2024, Volume: 14 Issue: 2, 561 - 571, 28.06.2024

Meryem Saban Güler , Hilal Yıldıran

https://doi.org/10.33808/clinexphealthsci.1356783

Abstract

Nobiletin is a polymethoxylated flavone found in citrus peels. Thanks to its chemical structure and biological activities, nobiletin has been shown to have a positive effect on many diseases. In recent years, there has been a growing interest in research focusing on the impact of nobiletin and its metabolites on different cancer types. Nobiletin exhibits anticancer properties by impeding the proliferation of cancer cells, disrupting the cancer cell cycle, facilitating apoptosis, and regulating signaling pathways implicated in cancer development. In addition, studies have shown that its use with chemotherapeutic agents inhibits multi-drug resistance. This review aims to evaluate the metabolic properties of nobiletin and its possible effects on cancer.

Keywords

Nobiletin, bioavailability, cancer, signaling pathways, antiproliferation

References

Nakajima A, Ohizumi Y. Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer’s disease and Parkinson’s disease. Int J Mol Sci. 2019;20(14):3380:1-14. DOI: 10.3390/ijms20143380.
Yarım GF, Çenesiz M, Yarım M, Kazak F. Nöroprotektif etkili bir flavonoid: Nobiletin. Harran Üniv Vet Fak Derg. 2017;6(1):102-107. DOI:10.31196/huvfd.325789. (Turkish).
Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF. Neuroprotective effects of citrus fruit-derived flavonoids, nobiletin, and tangeretin in Alzheimer’s and Parkinson’s disease. CNS Neurol Disord Drug Targets 2017;16(4):387-397. DOI: 10.2174/187.152.7316666.170.328113309.
Singh B, Singh JP, Kaur A, Singh N. Phenolic composition, antioxidant potential and health benefits of citrus peel. Food Res Int. 2020;132:109114:1-22. DOI: 10.1016/j.foodres.2020.
Huang H, Li L, Shi W, Liu H, Yang J, Yuan X, Wu L. The multifunctional effects of nobiletin and its metabolites in vivo and in vitro. Evid Based Complement Alternat Med. 2016;2016:2918796. DOI: 10.1155/2016/2918796.
Murakami A, Koshimizu K, Ohigashi H, Kuwahara S, Kuki W, Takahashi Y, Hosotani K, Kawahara S, Matsuoka Y. Characteristic rat tissue accumulation of nobiletin, a chemopreventivepolymethoxyflavonoid, in comparison with luteolin. Biofactors 2002;16(3-4):73-82. DOI: 10.1002/biof.552.016.0303.
Goh JXH, Tan LT, Goh JK, Chan KG, Pusparajah P, Lee LH, Goh BH. Nobiletin and derivatives: Functional compounds from citrus fruit peel for colon cancer chemoprevention. Cancers 2019;11(6):867:1-34. DOI: 10.3390/cancers11060867.
Hung WL, Chang WS, Lu WC, Wei GJ, Wang Y, Ho CT, Hwang LS. Pharmacokinetics, bioavailability, tissue distribution and excretion of tangeretin in rat. J Food Drug Anal. 2018;26(2):849-857. DOI: 10.1016/j.jfda.2017.08.003.
Youn K, Yu Y, Lee J, Jeong WS, Ho CT, Jun M. Polymethoxyflavones: Novel β-secretase (BACE1) inhibitors from citrus peels. Nutrients 2017;9(9):973:1-12. DOI: 10.3390/nu9090973.
Ashrafizadeh M, Zarrabi A, Saberifar S, Hashemi F, Hushmandi K, Hashemi F, Moghadam ER, Mohammadinejad R, Najafi M, Garg M. Nobiletin in cancer therapy: How this plant-derivednatural compound targets various oncogene and oncosuppressor pathways. Biomedicines 2020;8(5):110:1-31. DOI:10.3390/biomedicines8050110.
Wu X, Song M, Wang M, Zheng J, Gao Z, Xu F, Zhang G, Xiao H. Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis. Mol Nutr Food Res. 2015;59(12):2383-2394. DOI: 10.1002/mnfr.201500378.
Gan R, Liu Y, Li H, Xia Y, Guo H, Geng F, Zhuang Q, Li H, Wu D. Natural sources, refined extraction, biosynthesis, metabolism, and bioactivities of dietary polymethoxyflavones (PMFs). Food Sci Hum Wellness 2024;13(1):27-49. DOI: https://doi.org/10.26599/FSHW.2022.925.0003.
Onoue S, Nakamura T, Uchida A, Ogawa K, Yuminoki K, Hashimoto N, Hiza A, Tsukaguchi Y, Asakawa T, Kan T, Yamada S. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects. Eur J Pharm Sci. 2013;49(4):453-460. DOI: 10.1016/j.ejps.2013.05.014.
Hattori T, Tagawa H, Inai M, Kan T, Kimura S-i, Itai S, Mitragotri S, Iwao Y. Transdermal delivery of nobiletin using ionic liquids. Sci Rep. 2019;9(1):20191:1-11. DOI: 10.1038/s41598.019.56731-1.
Saigusa D, Shibuya M, Jinno D, Yamakoshi H, Iwabuchi Y, Yokosuka A, Mimaki Y, Naganuma A, Ohizumi Y, Tomioka Y, Yamakuni T. High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound. Anal Bioanal Chem. 2011;400(10):3635-3641. DOI: 10.1007/s00216.011.5031-2.
Singh SP, Wahajuddin, Tewari D, Patel K, Jain GK. Permeability determination and pharmacokinetic study of nobiletin in rat plasma and brain by validated high-performance liquid chromatography method. Fitoterapia 2011;82(8):1206-1214.DOI: 10.1016/j.fitote.2011.08.010.
Wu D, Liang Y, Pei Y, Li B, Liang H. Plant exine capsules based encapsulation strategy: A high loading and long-term effective delivery system for nobiletin. Food Res Int. 2020;127:108691:1-9. DOI: 10.1016/j.foodres.2019.108691.
Liao W, Liu Z, Zhang T, Sun S, Ye J, Li Z, Mao L, Ren J. Enhancement of anti-inflammatory properties of nobiletin in macrophages by a nano-emulsion preparation. J Agric Food Chem. 2018;66(1):91-98. DOI: 10.1021/acs.jafc.7b03953.
Wang Y, Xie J, Ai Z, Su J. Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis. Int J Nanomedicine 2019;14:7839 – 7849.DOI: 10.2147/IJN.S213724.
Chen YY, Liang JJ, Wang DL, Chen JB, Cao JP, Wang Y, Sun CD. Nobiletin as a chemopreventive natural product against cancer, a comprehensive review. Crit Rev Food Sci Nutr. 2023;63(23):6309– 6329. DOI: 10.1080/10408.398.2022.2030297.
Chen C, Ono M, Takeshima M, Nakano S. Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. Anticancer Res. 2014;34(4):1785-1792.
Rahideh ST, Keramatipour M, Nourbakhsh M, Koohdani F, Hoseini M, Talebi S, Shidfar F. Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line. Biochem Cell Biol. 2017;95(4):468-473. DOI: 10.1139/bcb-2016-0206.
Surichan S, Arroo RR, Ruparelia K, Tsatsakis AM, Androutsopoulos VP. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Food Chem Toxicol. 2018;113:228-235. DOI: 10.1016/j. fct.2018.01.047.
Sp N, Kang DY, Joung YH, Park JH, Kim WS, Lee HK, Song KD, Park YM, Yang YM. Nobiletin inhibits angiogenesis by regulating Src/FAK/STAT3-mediated signaling through PXN in ER⁺ breast cancer cells. Int J Mol Sci. 2017;18(5):935:1-13. DOI:10.3390/ijms18050935.
Liu J, Wang S, Tian S, He Y, Lou H, Yang Z, Kong Y, Cao X. Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-κB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells. Food Nutr Res. 2018;62:1323:1-10. DOI: 10.29219/fnr.v62.1323.
Wu X, Song M, Qiu P, Li F, Wang M, Zheng J, Wang Q , Xu F, Xiao H. A metabolite of nobiletin, 4’-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis. Food Funct. 2018;9(1):87-95. DOI: 10.1039/c7fo01155e.
Kawabata K, Murakami A, Ohigashi H. Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7(matrilysin) expression in HT-29 human colorectal cancer cells. Biosci Biotechnol Biochem. 2005;69(2):307-314. DOI:10.1271/bbb.69.307.
Jiang YP, Guo H, Wang XB. Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3/TAX ovarian cancer cells. Biomed Pharmacother. 2018;103:29-37. DOI:10.1016/j.biopha.2018.03.126.
Chen J, Chen AY, Huang H, Ye X, Rollyson WD, Perry HE, Brown KC, Rojanasakul Y, Rankin GO, Dasgupta P, Chen YC. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway. Int J Oncol. 2015;46(6):2629-2638. DOI: 10.3892/ijo.2015.2946.
Zhang R, Chen J, Mao L, Guo Y, Hao Y, Deng Y, Han X, Li Q, Liao W, Yuan M. Nobiletin triggers reactive oxygen speciesmediated pyroptosis through regulating autophagy in ovarian cancer cells. J Agric Food Chem. 2020;68(5):1326-1336. DOI:10.1021/acs.jafc.9b07908.
Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kameyama K, Fujii M, Yano M, Sato T, Ito A, Kitajima M. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment Pharmacol Ther. 2004;20 Suppl 1:95-101. DOI: 10.1111/j.1365-2036.2004.02082.x.
Moon JY, Cho M, Ahn KS, Cho SK. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells. Nutr Cancer. 2013;65(2):286-295. DOI:10.1080/01635.581.2013.756529.
Moon JY, Cho SK. Nobiletin induces protective autophagy accompanied by ER-stress mediated apoptosis in human gastric cancer SNU-16 cells. Molecules. 2016;21(7):914:1-13. DOI: 10.3390/molecules21070914.
Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin enhances chemosensitivity to adriamycin through modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 signaling pathway in A549 human non-small-cell lung cancer cells. Nutrients. 2018;10(12):1829:1-17. DOI: 10.3390/nu10121829.
Da C, Liu Y, Zhan Y, Liu K, Wang R. Nobiletin inhibits epithelial mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Oncol Rep. 2016;35(5):2767-2774. DOI: 10.3892/or.2016.4661.
Uesato S, Yamashita H, Maeda R, Hirata Y, Yamamoto M, Matsue S, Nagaoka Y, Shibano M, Taniguchi M, Baba K, Ju-ichi M. Synergistic antitumor effect of a combination of paclitaxel and carboplatin with nobiletin from citrus depressa on nonsmall-cell lung cancer cell lines. Planta Med. 2014;80(6):452-457. DOI: 10.1055/s-0034.136.8321.
Luo G, Guan X, Zhou L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther. 2008;7(6):966-973. DOI: 10.4161/cbt.7.6.5967.
Ma X, Jin S, Zhang Y, Wan L, Zhao Y, Zhou L. Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo. Phytother Res. 2014;28(4):560-567. DOI: 10.1002/ptr.5024.
Shi MD, Liao YC, Shih YW, Tsai LY. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Phytomedicine. 2013;20(8-9):743-752. DOI: 10.1016/j.phymed.2013.02.004.
Deveci Ozkan A, Kaleli S, Onen HI, Sarihan M, Guney Eskiler G, Kalayci Yigin A, Akdogan M. Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells. Immunopharmacol Immunotoxicol. 2020;42(2):93-100. DOI: 10.1080/08923.973.2020.1725040.
Chen J, Creed A, Chen AY, Huang H, Li Z, Rankin GO, Ye X, Xu G, Chen YC. Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells. BMC Pharmacol Toxicol. 2014;15:59:1-10. DOI: 10.1186/2050- 6511-15-59.
Tang M, Ogawa K, Asamoto M, Hokaiwado N, Seeni A, Suzuki S, Takahashi S, Tanaka T, Ichikawa K, Shirai T. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci. 2007;98(4):471-477. DOI:10.1111/j.1349-7006.2007.00417.x.
Goan YG, Wu WT, Liu CI, Neoh CA, Wu YJ. Involvement of mitochondrial dysfunction, endoplasmic reticulum stress, and the PI3K/AKT/mTOR pathway in nobiletin-induced apoptosis of human bladder cancer cells. Molecules 2019;24(16):2881:1-14. DOI: 10.3390/molecules24162881.
Sousa DP, Pojo M, Pinto AT, Leite V, Serra AT, Cavaco BM. Nobiletin alone or in combination with cisplatin decreases the viability of anaplastic thyroid cancer cell lines. Nutr Cancer 2020;72(2):352-363. DOI:10.1080/01635.581.2019.1634745.
Zheng GD, Hu PJ, Chao YX, Zhou Y, Yang XJ, Chen BZ, Yu XY, Cai Y. Nobiletin induces growth inhibition and apoptosisin human nasopharyngeal carcinoma C666-1 cells through regulating PARP-2/SIRT1/AMPK signaling pathway. Food Sci Nutr. 2019;7(3):1104-1112. DOI: 10.1002/fsn3.953.
Chien SY, Hsieh MJ, Chen CJ, Yang SF, Chen MK. Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2. Expert Opin Ther Targets 2015;19(3):307-320. DOI: 10.1517/14728.222.2014.992875.
Wei D, Zhang G, Zhu Z, Zheng Y, Yan F, Pan C, Wang Z, Li X, Wang F, Meng P, Zheng W, Yan Z, Zhai D, Lu Z, Yuan J. Nobiletin inhibits cell viability via the SRC/AKT/STAT3/YY1AP1 pathway in human renal carcinoma cells. Front Pharmacol. 2019;10:690:1-14. DOI: 10.3389/fphar.2019.00690.
Liu F, Zhang S, Yin M, Guo L, Xu M, Wang Y. Nobiletin inhibits hypoxia-induced epithelial-mesenchymal transition in renal cell carcinoma cells. J Cell Biochem. 2018;120:2039-2046. DOI: 10.1002/jcb.27511.
Cheng HL, Hsieh MJ, Yang JS, Lin CW, Lue KH, Lu KH, Yang SF. Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget 2016;7(23):35208-35223. DOI:10.18632/oncotarget.9106.
Li S, Sang S, Pan MH, Lai CS, Lo CY, Yang CS, Ho CT. Antiinflammatory property of the urinary metabolites of nobiletin in mouse. Bioorg Med Chem Lett. 2007;17(18):5177-5181. DOI: 10.1016/j.bmcl.2007.06.096.
Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Cancer Genome Atlas Research Network; Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N. Oncogenic signaling pathways in the cancer genome atlas. Cell 2018;173(2):321-337.e10. DOI: 10.1016/j.cell.2018.03.035.
Doğan AL, Güç D. Sinyal iletimi mekanizmaları ve kanser. Acta Medica. 2004;35(1): 34-42. (Turkish).
Pehlivanoğlu B, Aysal A, Ekmekci S, Şahin Y, Toper MH, Gündoğdu B, Erdoğdu İH, Kelten Talu C. Neoplastik hastalıkların moleküler patolojik mekanizmaları. J Curr Pathol. 2019;3(2):62-80. DOI: 10.5146/jcpath.2019.48. (Turkish).
Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun. 2008;366(1):168-173. DOI: 10.1016/j.bbrc.2007.11.100.
Guney Eskiler G, Deveci AO, Bilir C, Kaleli S. Synergistic effects of nobiletin and sorafenib combination on metastatic prostate cancer cells. Nutr Cancer 2019;71(8):1299-1312. DOI:10.1080/01635.581.2019.1601237.
Chung SD, Lai TY, Chien CT, Yu HJ. Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney. PLoS One 2012;7(10):e47299:1-13. DOI: 10.1371/journal.pone.0047299.
Ma SM, Mao Q, Yi L, Zhao MQ, Chen JD. Apoptosis, autophagy, and pyroptosis: immune escape strategies for persistent infection and pathogenesis of classical swinefever virus. Pathogens 2019;8(4):239:1-13. DOI: 10.3390/ pathogens8040239.
Kartlaşmış K, Kökbaş U, Kayrın L. Apoptozisin biyokimyası. Arşiv Kaynak Tarama Derg. 2016;25(1):52-69. DOI: 10.17827/Aktd.16717. (Turkish).
Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010;15(2):117-134. DOI: 10.1007/s10911.010.9178-9.
Petric Z, Žuntar I, Putnik P, Bursać Kovačević D. Food-drug interactions with fruit juices. Foods. 2020;10(1):33:1-14. DOI: 10.3390/foods10010033.
Vuong M, González Aragón C, Montarroyos SS. Common food and drug interactions. Pediatr Rev. 2023;44(2):68-80. DOI:10.1542/pir.2022-005641.
Weiss J, Gattuso G, Barreca D, Haefeli WE. Nobiletin, sinensetin, and tangeretin are the main perpetrators in clementines provoking food-drug interactions in vitro. Food Chem. 2020;319:126578:1-10. DOI: 10.1016/j.foodchem.2020.126578.
Ma W, Feng S, Yao X, Yuan Z, Liu L, Xie Y. Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells. Sci Rep. 2015;5:18789:1-15. DOI: 10.1038/srep18789.
Feng S, Zhou H, Wu D, Zheng D, Qu B, Liu R, Zhang C, Li Z, Xie Y, Luo HB. Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents. Acta Pharm Sin B. 2020;10(2):327-343. DOI: 10.1016/j.apsb.2019.07.007.
Callaghan R, Luk F, Bebawy M. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Drug Metab Dispos. 2014;42(4):623-631. DOI: 10.1124/dmd.113.056176.
Güney Eskiler G, Deveci Özkan A, Kaleli S. Metastatik prostat kanserinde nobiletinin sitotoksik ve apoptotik etkisinin belirlenmesi. Sakarya Tıp Derg. 2018;8(4):766-774. (Turkish).
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis V, Azimonti G, Bastos ML, Christensen H, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Brantom P, Chesson A, Westendorf J, Manini P, Pizzo F, Dusemund B. Safety and efficacy of feed additives consisting of expressed sweet orange peel oil and its fractions from Citrus sinensis (L.) Osbeck for use in all animal species (FEFANA asbl). EFSA J. 2021 Nov 19;19(11):e06891:1-39. DOI: 10.2903/j.efsa.2021.6891.
Nakajima A, Nemoto K, Ohizumi Y. An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar ‘Ohta ponkan’ (Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity. Regul Toxicol Pharmacol. 2020;114:104670:1-10. DOI: 10.1016/j.yrtph.2020.104670.
Sp N, Kang DY, Kim DH, Park JH, Lee HG, Kim HJ, Darvin P, Park YM, Yang YM. Nobiletin inhibits CD36-dependent tumor angiogenesis, migration, invasion, and sphere formation through the Cd36/Stat3/Nf-Κb signaling axis. Nutrients 2018;10(6):772:1-15. DOI: 10.3390/nu10060772.
Li N, Zhang Z, Jiang G, Sun H, Yu D. Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/mTOR pathway. Front Biosci (Landmark Ed). 2019;24:303-312. DOI: 10.2741/4719.
Küçükkaya B, Afrasyap L. Mitojenle etkinleşen protein kinazların heterotrimerik G proteinleri ile düzenlenmesi. Turk J Bioch. 2013;38(2):218–228. (Turkish).

Year 2024, Volume: 14 Issue: 2, 561 - 571, 28.06.2024

Meryem Saban Güler , Hilal Yıldıran

https://doi.org/10.33808/clinexphealthsci.1356783

Abstract

References

Nakajima A, Ohizumi Y. Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer’s disease and Parkinson’s disease. Int J Mol Sci. 2019;20(14):3380:1-14. DOI: 10.3390/ijms20143380.
Yarım GF, Çenesiz M, Yarım M, Kazak F. Nöroprotektif etkili bir flavonoid: Nobiletin. Harran Üniv Vet Fak Derg. 2017;6(1):102-107. DOI:10.31196/huvfd.325789. (Turkish).
Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF. Neuroprotective effects of citrus fruit-derived flavonoids, nobiletin, and tangeretin in Alzheimer’s and Parkinson’s disease. CNS Neurol Disord Drug Targets 2017;16(4):387-397. DOI: 10.2174/187.152.7316666.170.328113309.
Singh B, Singh JP, Kaur A, Singh N. Phenolic composition, antioxidant potential and health benefits of citrus peel. Food Res Int. 2020;132:109114:1-22. DOI: 10.1016/j.foodres.2020.
Huang H, Li L, Shi W, Liu H, Yang J, Yuan X, Wu L. The multifunctional effects of nobiletin and its metabolites in vivo and in vitro. Evid Based Complement Alternat Med. 2016;2016:2918796. DOI: 10.1155/2016/2918796.
Murakami A, Koshimizu K, Ohigashi H, Kuwahara S, Kuki W, Takahashi Y, Hosotani K, Kawahara S, Matsuoka Y. Characteristic rat tissue accumulation of nobiletin, a chemopreventivepolymethoxyflavonoid, in comparison with luteolin. Biofactors 2002;16(3-4):73-82. DOI: 10.1002/biof.552.016.0303.
Goh JXH, Tan LT, Goh JK, Chan KG, Pusparajah P, Lee LH, Goh BH. Nobiletin and derivatives: Functional compounds from citrus fruit peel for colon cancer chemoprevention. Cancers 2019;11(6):867:1-34. DOI: 10.3390/cancers11060867.
Hung WL, Chang WS, Lu WC, Wei GJ, Wang Y, Ho CT, Hwang LS. Pharmacokinetics, bioavailability, tissue distribution and excretion of tangeretin in rat. J Food Drug Anal. 2018;26(2):849-857. DOI: 10.1016/j.jfda.2017.08.003.
Youn K, Yu Y, Lee J, Jeong WS, Ho CT, Jun M. Polymethoxyflavones: Novel β-secretase (BACE1) inhibitors from citrus peels. Nutrients 2017;9(9):973:1-12. DOI: 10.3390/nu9090973.
Ashrafizadeh M, Zarrabi A, Saberifar S, Hashemi F, Hushmandi K, Hashemi F, Moghadam ER, Mohammadinejad R, Najafi M, Garg M. Nobiletin in cancer therapy: How this plant-derivednatural compound targets various oncogene and oncosuppressor pathways. Biomedicines 2020;8(5):110:1-31. DOI:10.3390/biomedicines8050110.
Wu X, Song M, Wang M, Zheng J, Gao Z, Xu F, Zhang G, Xiao H. Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis. Mol Nutr Food Res. 2015;59(12):2383-2394. DOI: 10.1002/mnfr.201500378.
Gan R, Liu Y, Li H, Xia Y, Guo H, Geng F, Zhuang Q, Li H, Wu D. Natural sources, refined extraction, biosynthesis, metabolism, and bioactivities of dietary polymethoxyflavones (PMFs). Food Sci Hum Wellness 2024;13(1):27-49. DOI: https://doi.org/10.26599/FSHW.2022.925.0003.
Onoue S, Nakamura T, Uchida A, Ogawa K, Yuminoki K, Hashimoto N, Hiza A, Tsukaguchi Y, Asakawa T, Kan T, Yamada S. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects. Eur J Pharm Sci. 2013;49(4):453-460. DOI: 10.1016/j.ejps.2013.05.014.
Hattori T, Tagawa H, Inai M, Kan T, Kimura S-i, Itai S, Mitragotri S, Iwao Y. Transdermal delivery of nobiletin using ionic liquids. Sci Rep. 2019;9(1):20191:1-11. DOI: 10.1038/s41598.019.56731-1.
Saigusa D, Shibuya M, Jinno D, Yamakoshi H, Iwabuchi Y, Yokosuka A, Mimaki Y, Naganuma A, Ohizumi Y, Tomioka Y, Yamakuni T. High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound. Anal Bioanal Chem. 2011;400(10):3635-3641. DOI: 10.1007/s00216.011.5031-2.
Singh SP, Wahajuddin, Tewari D, Patel K, Jain GK. Permeability determination and pharmacokinetic study of nobiletin in rat plasma and brain by validated high-performance liquid chromatography method. Fitoterapia 2011;82(8):1206-1214.DOI: 10.1016/j.fitote.2011.08.010.
Wu D, Liang Y, Pei Y, Li B, Liang H. Plant exine capsules based encapsulation strategy: A high loading and long-term effective delivery system for nobiletin. Food Res Int. 2020;127:108691:1-9. DOI: 10.1016/j.foodres.2019.108691.
Liao W, Liu Z, Zhang T, Sun S, Ye J, Li Z, Mao L, Ren J. Enhancement of anti-inflammatory properties of nobiletin in macrophages by a nano-emulsion preparation. J Agric Food Chem. 2018;66(1):91-98. DOI: 10.1021/acs.jafc.7b03953.
Wang Y, Xie J, Ai Z, Su J. Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis. Int J Nanomedicine 2019;14:7839 – 7849.DOI: 10.2147/IJN.S213724.
Chen YY, Liang JJ, Wang DL, Chen JB, Cao JP, Wang Y, Sun CD. Nobiletin as a chemopreventive natural product against cancer, a comprehensive review. Crit Rev Food Sci Nutr. 2023;63(23):6309– 6329. DOI: 10.1080/10408.398.2022.2030297.
Chen C, Ono M, Takeshima M, Nakano S. Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. Anticancer Res. 2014;34(4):1785-1792.
Rahideh ST, Keramatipour M, Nourbakhsh M, Koohdani F, Hoseini M, Talebi S, Shidfar F. Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line. Biochem Cell Biol. 2017;95(4):468-473. DOI: 10.1139/bcb-2016-0206.
Surichan S, Arroo RR, Ruparelia K, Tsatsakis AM, Androutsopoulos VP. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Food Chem Toxicol. 2018;113:228-235. DOI: 10.1016/j. fct.2018.01.047.
Sp N, Kang DY, Joung YH, Park JH, Kim WS, Lee HK, Song KD, Park YM, Yang YM. Nobiletin inhibits angiogenesis by regulating Src/FAK/STAT3-mediated signaling through PXN in ER⁺ breast cancer cells. Int J Mol Sci. 2017;18(5):935:1-13. DOI:10.3390/ijms18050935.
Liu J, Wang S, Tian S, He Y, Lou H, Yang Z, Kong Y, Cao X. Nobiletin inhibits breast cancer via p38 mitogen-activated protein kinase, nuclear transcription factor-κB, and nuclear factor erythroid 2-related factor 2 pathways in MCF-7 cells. Food Nutr Res. 2018;62:1323:1-10. DOI: 10.29219/fnr.v62.1323.
Wu X, Song M, Qiu P, Li F, Wang M, Zheng J, Wang Q , Xu F, Xiao H. A metabolite of nobiletin, 4’-demethylnobiletin and atorvastatin synergistically inhibits human colon cancer cell growth by inducing G0/G1 cell cycle arrest and apoptosis. Food Funct. 2018;9(1):87-95. DOI: 10.1039/c7fo01155e.
Kawabata K, Murakami A, Ohigashi H. Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7(matrilysin) expression in HT-29 human colorectal cancer cells. Biosci Biotechnol Biochem. 2005;69(2):307-314. DOI:10.1271/bbb.69.307.
Jiang YP, Guo H, Wang XB. Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3/TAX ovarian cancer cells. Biomed Pharmacother. 2018;103:29-37. DOI:10.1016/j.biopha.2018.03.126.
Chen J, Chen AY, Huang H, Ye X, Rollyson WD, Perry HE, Brown KC, Rojanasakul Y, Rankin GO, Dasgupta P, Chen YC. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway. Int J Oncol. 2015;46(6):2629-2638. DOI: 10.3892/ijo.2015.2946.
Zhang R, Chen J, Mao L, Guo Y, Hao Y, Deng Y, Han X, Li Q, Liao W, Yuan M. Nobiletin triggers reactive oxygen speciesmediated pyroptosis through regulating autophagy in ovarian cancer cells. J Agric Food Chem. 2020;68(5):1326-1336. DOI:10.1021/acs.jafc.9b07908.
Yoshimizu N, Otani Y, Saikawa Y, Kubota T, Yoshida M, Furukawa T, Kumai K, Kameyama K, Fujii M, Yano M, Sato T, Ito A, Kitajima M. Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment Pharmacol Ther. 2004;20 Suppl 1:95-101. DOI: 10.1111/j.1365-2036.2004.02082.x.
Moon JY, Cho M, Ahn KS, Cho SK. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells. Nutr Cancer. 2013;65(2):286-295. DOI:10.1080/01635.581.2013.756529.
Moon JY, Cho SK. Nobiletin induces protective autophagy accompanied by ER-stress mediated apoptosis in human gastric cancer SNU-16 cells. Molecules. 2016;21(7):914:1-13. DOI: 10.3390/molecules21070914.
Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin enhances chemosensitivity to adriamycin through modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 signaling pathway in A549 human non-small-cell lung cancer cells. Nutrients. 2018;10(12):1829:1-17. DOI: 10.3390/nu10121829.
Da C, Liu Y, Zhan Y, Liu K, Wang R. Nobiletin inhibits epithelial mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Oncol Rep. 2016;35(5):2767-2774. DOI: 10.3892/or.2016.4661.
Uesato S, Yamashita H, Maeda R, Hirata Y, Yamamoto M, Matsue S, Nagaoka Y, Shibano M, Taniguchi M, Baba K, Ju-ichi M. Synergistic antitumor effect of a combination of paclitaxel and carboplatin with nobiletin from citrus depressa on nonsmall-cell lung cancer cell lines. Planta Med. 2014;80(6):452-457. DOI: 10.1055/s-0034.136.8321.
Luo G, Guan X, Zhou L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther. 2008;7(6):966-973. DOI: 10.4161/cbt.7.6.5967.
Ma X, Jin S, Zhang Y, Wan L, Zhao Y, Zhou L. Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo. Phytother Res. 2014;28(4):560-567. DOI: 10.1002/ptr.5024.
Shi MD, Liao YC, Shih YW, Tsai LY. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Phytomedicine. 2013;20(8-9):743-752. DOI: 10.1016/j.phymed.2013.02.004.
Deveci Ozkan A, Kaleli S, Onen HI, Sarihan M, Guney Eskiler G, Kalayci Yigin A, Akdogan M. Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells. Immunopharmacol Immunotoxicol. 2020;42(2):93-100. DOI: 10.1080/08923.973.2020.1725040.
Chen J, Creed A, Chen AY, Huang H, Li Z, Rankin GO, Ye X, Xu G, Chen YC. Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells. BMC Pharmacol Toxicol. 2014;15:59:1-10. DOI: 10.1186/2050- 6511-15-59.
Tang M, Ogawa K, Asamoto M, Hokaiwado N, Seeni A, Suzuki S, Takahashi S, Tanaka T, Ichikawa K, Shirai T. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci. 2007;98(4):471-477. DOI:10.1111/j.1349-7006.2007.00417.x.
Goan YG, Wu WT, Liu CI, Neoh CA, Wu YJ. Involvement of mitochondrial dysfunction, endoplasmic reticulum stress, and the PI3K/AKT/mTOR pathway in nobiletin-induced apoptosis of human bladder cancer cells. Molecules 2019;24(16):2881:1-14. DOI: 10.3390/molecules24162881.
Sousa DP, Pojo M, Pinto AT, Leite V, Serra AT, Cavaco BM. Nobiletin alone or in combination with cisplatin decreases the viability of anaplastic thyroid cancer cell lines. Nutr Cancer 2020;72(2):352-363. DOI:10.1080/01635.581.2019.1634745.
Zheng GD, Hu PJ, Chao YX, Zhou Y, Yang XJ, Chen BZ, Yu XY, Cai Y. Nobiletin induces growth inhibition and apoptosisin human nasopharyngeal carcinoma C666-1 cells through regulating PARP-2/SIRT1/AMPK signaling pathway. Food Sci Nutr. 2019;7(3):1104-1112. DOI: 10.1002/fsn3.953.
Chien SY, Hsieh MJ, Chen CJ, Yang SF, Chen MK. Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2. Expert Opin Ther Targets 2015;19(3):307-320. DOI: 10.1517/14728.222.2014.992875.
Wei D, Zhang G, Zhu Z, Zheng Y, Yan F, Pan C, Wang Z, Li X, Wang F, Meng P, Zheng W, Yan Z, Zhai D, Lu Z, Yuan J. Nobiletin inhibits cell viability via the SRC/AKT/STAT3/YY1AP1 pathway in human renal carcinoma cells. Front Pharmacol. 2019;10:690:1-14. DOI: 10.3389/fphar.2019.00690.
Liu F, Zhang S, Yin M, Guo L, Xu M, Wang Y. Nobiletin inhibits hypoxia-induced epithelial-mesenchymal transition in renal cell carcinoma cells. J Cell Biochem. 2018;120:2039-2046. DOI: 10.1002/jcb.27511.
Cheng HL, Hsieh MJ, Yang JS, Lin CW, Lue KH, Lu KH, Yang SF. Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget 2016;7(23):35208-35223. DOI:10.18632/oncotarget.9106.
Li S, Sang S, Pan MH, Lai CS, Lo CY, Yang CS, Ho CT. Antiinflammatory property of the urinary metabolites of nobiletin in mouse. Bioorg Med Chem Lett. 2007;17(18):5177-5181. DOI: 10.1016/j.bmcl.2007.06.096.
Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Cancer Genome Atlas Research Network; Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N. Oncogenic signaling pathways in the cancer genome atlas. Cell 2018;173(2):321-337.e10. DOI: 10.1016/j.cell.2018.03.035.
Doğan AL, Güç D. Sinyal iletimi mekanizmaları ve kanser. Acta Medica. 2004;35(1): 34-42. (Turkish).
Pehlivanoğlu B, Aysal A, Ekmekci S, Şahin Y, Toper MH, Gündoğdu B, Erdoğdu İH, Kelten Talu C. Neoplastik hastalıkların moleküler patolojik mekanizmaları. J Curr Pathol. 2019;3(2):62-80. DOI: 10.5146/jcpath.2019.48. (Turkish).
Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun. 2008;366(1):168-173. DOI: 10.1016/j.bbrc.2007.11.100.
Guney Eskiler G, Deveci AO, Bilir C, Kaleli S. Synergistic effects of nobiletin and sorafenib combination on metastatic prostate cancer cells. Nutr Cancer 2019;71(8):1299-1312. DOI:10.1080/01635.581.2019.1601237.
Chung SD, Lai TY, Chien CT, Yu HJ. Activating Nrf-2 signaling depresses unilateral ureteral obstruction-evoked mitochondrial stress-related autophagy, apoptosis and pyroptosis in kidney. PLoS One 2012;7(10):e47299:1-13. DOI: 10.1371/journal.pone.0047299.
Ma SM, Mao Q, Yi L, Zhao MQ, Chen JD. Apoptosis, autophagy, and pyroptosis: immune escape strategies for persistent infection and pathogenesis of classical swinefever virus. Pathogens 2019;8(4):239:1-13. DOI: 10.3390/ pathogens8040239.
Kartlaşmış K, Kökbaş U, Kayrın L. Apoptozisin biyokimyası. Arşiv Kaynak Tarama Derg. 2016;25(1):52-69. DOI: 10.17827/Aktd.16717. (Turkish).
Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010;15(2):117-134. DOI: 10.1007/s10911.010.9178-9.
Petric Z, Žuntar I, Putnik P, Bursać Kovačević D. Food-drug interactions with fruit juices. Foods. 2020;10(1):33:1-14. DOI: 10.3390/foods10010033.
Vuong M, González Aragón C, Montarroyos SS. Common food and drug interactions. Pediatr Rev. 2023;44(2):68-80. DOI:10.1542/pir.2022-005641.
Weiss J, Gattuso G, Barreca D, Haefeli WE. Nobiletin, sinensetin, and tangeretin are the main perpetrators in clementines provoking food-drug interactions in vitro. Food Chem. 2020;319:126578:1-10. DOI: 10.1016/j.foodchem.2020.126578.
Ma W, Feng S, Yao X, Yuan Z, Liu L, Xie Y. Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells. Sci Rep. 2015;5:18789:1-15. DOI: 10.1038/srep18789.
Feng S, Zhou H, Wu D, Zheng D, Qu B, Liu R, Zhang C, Li Z, Xie Y, Luo HB. Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents. Acta Pharm Sin B. 2020;10(2):327-343. DOI: 10.1016/j.apsb.2019.07.007.
Callaghan R, Luk F, Bebawy M. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Drug Metab Dispos. 2014;42(4):623-631. DOI: 10.1124/dmd.113.056176.
Güney Eskiler G, Deveci Özkan A, Kaleli S. Metastatik prostat kanserinde nobiletinin sitotoksik ve apoptotik etkisinin belirlenmesi. Sakarya Tıp Derg. 2018;8(4):766-774. (Turkish).
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis V, Azimonti G, Bastos ML, Christensen H, Fašmon Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Sanz Y, Villa RE, Woutersen R, Brantom P, Chesson A, Westendorf J, Manini P, Pizzo F, Dusemund B. Safety and efficacy of feed additives consisting of expressed sweet orange peel oil and its fractions from Citrus sinensis (L.) Osbeck for use in all animal species (FEFANA asbl). EFSA J. 2021 Nov 19;19(11):e06891:1-39. DOI: 10.2903/j.efsa.2021.6891.
Nakajima A, Nemoto K, Ohizumi Y. An evaluation of the genotoxicity and subchronic toxicity of the peel extract of Ponkan cultivar ‘Ohta ponkan’ (Citrus reticulata Blanco) that is rich in nobiletin and tangeretin with anti-dementia activity. Regul Toxicol Pharmacol. 2020;114:104670:1-10. DOI: 10.1016/j.yrtph.2020.104670.
Sp N, Kang DY, Kim DH, Park JH, Lee HG, Kim HJ, Darvin P, Park YM, Yang YM. Nobiletin inhibits CD36-dependent tumor angiogenesis, migration, invasion, and sphere formation through the Cd36/Stat3/Nf-Κb signaling axis. Nutrients 2018;10(6):772:1-15. DOI: 10.3390/nu10060772.
Li N, Zhang Z, Jiang G, Sun H, Yu D. Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/mTOR pathway. Front Biosci (Landmark Ed). 2019;24:303-312. DOI: 10.2741/4719.
Küçükkaya B, Afrasyap L. Mitojenle etkinleşen protein kinazların heterotrimerik G proteinleri ile düzenlenmesi. Turk J Bioch. 2013;38(2):218–228. (Turkish).

There are 71 citations in total.

Details

Primary Language	English
Subjects	Food Properties, Food Nutritional Balance
Journal Section	Review
Authors	Meryem Saban Güler 0000-0002-7202-0524 Hilal Yıldıran 0000-0001-7956-5087
Publication Date	June 28, 2024
Submission Date	September 12, 2023
Published in Issue	Year 2024 Volume: 14 Issue: 2

Cite

APA	Saban Güler, M., & Yıldıran, H. (2024). Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties. Clinical and Experimental Health Sciences, 14(2), 561-571. https://doi.org/10.33808/clinexphealthsci.1356783
AMA	Saban Güler M, Yıldıran H. Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties. Clinical and Experimental Health Sciences. June 2024;14(2):561-571. doi:10.33808/clinexphealthsci.1356783
Chicago	Saban Güler, Meryem, and Hilal Yıldıran. “Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-Tumor Properties”. Clinical and Experimental Health Sciences 14, no. 2 (June 2024): 561-71. https://doi.org/10.33808/clinexphealthsci.1356783.
EndNote	Saban Güler M, Yıldıran H (June 1, 2024) Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties. Clinical and Experimental Health Sciences 14 2 561–571.
IEEE	M. Saban Güler and H. Yıldıran, “Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties”, Clinical and Experimental Health Sciences, vol. 14, no. 2, pp. 561–571, 2024, doi: 10.33808/clinexphealthsci.1356783.
ISNAD	Saban Güler, Meryem - Yıldıran, Hilal. “Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-Tumor Properties”. Clinical and Experimental Health Sciences 14/2 (June 2024), 561-571. https://doi.org/10.33808/clinexphealthsci.1356783.
JAMA	Saban Güler M, Yıldıran H. Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties. Clinical and Experimental Health Sciences. 2024;14:561–571.
MLA	Saban Güler, Meryem and Hilal Yıldıran. “Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-Tumor Properties”. Clinical and Experimental Health Sciences, vol. 14, no. 2, 2024, pp. 561-7, doi:10.33808/clinexphealthsci.1356783.
Vancouver	Saban Güler M, Yıldıran H. Comprehensive Review of Nobiletin, a Citrus Flavonoid: Metabolism and Anti-tumor Properties. Clinical and Experimental Health Sciences. 2024;14(2):561-7.

Download Cover Image

Article Files

Full Text